EMA – Page 2 – THE OVAL CIRCLE

EU

EU drugs regulator lists rare neurological disorder as potential side effect of Janssen’s Covid jab

Posted on July 26, 2021July 26, 2021By Editor

The European Medicines Agency (EMA) has listed Guillain-Barré syndrome (GBS) as a very rare side effect of the Janssen Covid vaccine after examining 108 cases and one death worldwide from among recipients of the jab. … Read More >EU drugs regulator lists rare neurological disorder as potential side effect of Janssen’s Covid jab

EU

EU drugs regulator urges people to follow through on 2nd Covid vaccine doses as Delta variant continues to surge in Europe

Posted on July 15, 2021July 15, 2021By Editor

As the Delta variant becomes increasingly prevalent, the European Medicines Agency (EMA) has urged citizens to get their second Covid-19 vaccine shot. It is also reviewing reported side-effects of Johnson & Johnson’s jab. … Read More >EU drugs regulator urges people to follow through on 2nd Covid vaccine doses as Delta variant continues to surge in Europe

EU

Europe’s drug regulator urges heart condition to be added to list of potential side effects of mRNA Covid vaccines

Posted on July 9, 2021July 9, 2021By Editor

The European Medicines Agency (EMA) has found a link connecting mRNA vaccines, such as Pfizer and Moderna, to rare heart conditions following inoculation, and has recommended that these side effects are listed. … Read More >Europe’s drug regulator urges heart condition to be added to list of potential side effects of mRNA Covid vaccines

Indians cry ‘discrimination’ as AstraZeneca’s local vaccine left off EU’s green list, but identical European-made one included

Posted on July 1, 2021July 1, 2021By Editor

People in India have slammed a decision by the European Union not to include the Indian-made Covishield vaccine – a locally produced copy of the AstraZeneca shot – in its vaccine passport program, labeling it an “insult.” … Read More >Indians cry ‘discrimination’ as AstraZeneca’s local vaccine left off EU’s green list, but identical European-made one included

EU

EU drugs regulator says it won’t impose 50% efficacy threshold for Covid-19 vaccines after disappointing result in CureVac trial

Posted on June 20, 2021June 20, 2021By Editor

The European Medicines Agency (EMA) has said it will not bring in a minimum efficacy threshold for Covid-19 vaccines. The comment comes after clinical trials showed Germany’s CureVac jab to be only 47% effective against the virus. … Read More >EU drugs regulator says it won’t impose 50% efficacy threshold for Covid-19 vaccines after disappointing result in CureVac trial

EU

EU batches of J&J Covid-19 vaccine withheld as ‘precaution’ after contamination at US factory – EMA

Posted on June 13, 2021June 13, 2021By Editor

The European Medicines Agency (EMA) has said it is aware of a contaminated batch of the active substance used to make Johnson & Johnson’s Covid-19 vaccine and that they’re taking precautionary action to prevent possible harm. … Read More >EU batches of J&J Covid-19 vaccine withheld as ‘precaution’ after contamination at US factory – EMA

EU

EU drugs regulator approves Pfizer’s Covid-19 vaccine for use in children aged 12 to 15

Posted on May 31, 2021By Editor

The European Medicines Agency (EMA) has approved the Covid-19 vaccine made by US-German partnership Pfizer-BioNTech for children aged 12 to 15, allowing kids in the bloc to be vaccinated against the virus for the first time. … Read More >EU drugs regulator approves Pfizer’s Covid-19 vaccine for use in children aged 12 to 15

EU

EU drug regulator launches real-time review of China’s Sinovac coronavirus vaccine

Posted on May 5, 2021May 5, 2021By Editor

The European medicines regulator has started a real-time review of Sinovac’s Covid-19 vaccine, with the drug becoming the first Chinese-developed jab to be evaluated by the bloc. … Read More >EU drug regulator launches real-time review of China’s Sinovac coronavirus vaccine

EU

EMA says J&J Covid-19 vaccine benefits outweigh the risks despite finding possible link to rare blood clots

Posted on April 21, 2021April 21, 2021By Editor

The European Medicines Agency (EMA) has given its backing to the Johnson & Johnson Covid-19 vaccine, saying the overall benefit-risk remains positive, despite warning about the very rare possible side effect of blood clots. … Read More >EMA says J&J Covid-19 vaccine benefits outweigh the risks despite finding possible link to rare blood clots

EU

Sweden halts J&J vaccine rollout until EU regulator reviews US reports of ‘very rare’ blood clot cases

Posted on April 16, 2021April 16, 2021By Editor

Sweden won’t start vaccinating people with Johnson & Johnson’s Covid-19 shot until the European Medicines Agency (EMA) reviews reports of rare blood clots possibly caused by it in the US, the Swedish Health Agency said. … Read More >Sweden halts J&J vaccine rollout until EU regulator reviews US reports of ‘very rare’ blood clot cases